Gov. Jared Polis announced statewide boards and commissions appointments on New Year’s Eve, and there was one appointment of someone from the Grand Valley. Polis reappointed Grand Junction’s Melissa ...
ATLANTA — It’s been more than a decade since someone last had to pay a toll to drive on Georgia 400. But soon, paid lanes will return to GA400 with new Express Lanes set to be built. Channel 2’s ...
Intelligent Bio on Wednesday announced a new strategic manufacturing partnership with Syrma Johari MedTech Ltd. to support and scale the production of its Intelligent Fingerprinting Drug Screening ...
This year is coming to an end, but When Calls the Heart fans have a lot to look forward to in the new year, seeing as a new season will start right at the start of the 2026 TV schedule. Season 13 is ...
・The deal values Amicus at $14.50 per share, representing a 33% premium to its $10.90 closing price on Thursday. ・Amicus settled its patent dispute with Indian drugmakers Aurobindo Pharma and Lupin ...
Dyadic Applied BioSolutions expanded its collaboration with Fermbox Bio, a biotech research & manufacturing company developing and delivering bio-based products through precision fermentation and ...
Below Deck Med‘s Nathan Gallagher is getting some backlash — including from his former costars — for his comments on the Bondi Beach shooting. Nathan took to Instagram on Monday, December 15, to ...
Siemens Healthineers AG became the latest company to sign a licensing agreement with Alzpath Inc. to use its pTau217 antibody in the development of a blood-based diagnostic assay for Alzheimer's ...
iRobot, the maker of the Roomba vacuum cleaner, filed for bankruptcy protection on Sunday and is pursuing a buyout from its primary manufacturer in China after the company's acquisition by Amazon was ...
(RTTNews) - XOMA Royalty Corporation (XOMA), a biotechnology royalty aggregator, has agreed to acquire Generation Bio Co. (GBIO), a clinical-stage company historically focused on T cell-driven ...
Dren Bio, a privately held, clinical-stage biotechnology company, has a new collaboration with Sanofi SA (NASDAQ: SNY). The new agreement is built on the existing relationship between the two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results